These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 24306659)

  • 1. Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998-2009.
    Gnerlich JL; Williams RT; Yao K; Jaskowiak N; Kulkarni SA
    Ann Surg Oncol; 2014 Apr; 21(4):1222-30. PubMed ID: 24306659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome.
    Onkendi EO; Jimenez RE; Spears GM; Harmsen WS; Ballman KV; Hieken TJ
    Ann Surg Oncol; 2014 Oct; 21(10):3304-9. PubMed ID: 25034817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phyllodes tumor of the breast.
    Belkacémi Y; Bousquet G; Marsiglia H; Ray-Coquard I; Magné N; Malard Y; Lacroix M; Gutierrez C; Senkus E; Christie D; Drumea K; Lagneau E; Kadish SP; Scandolaro L; Azria D; Ozsahin M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):492-500. PubMed ID: 17931796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cystosarcoma phylloides of the breast. A retrospective analysis of 12 cases].
    Mallebré B; Ebert A; Perez-Cantó A; Hopp H; Opril F; Weitzel H
    Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):35-40. PubMed ID: 8852784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program.
    Macdonald OK; Lee CM; Tward JD; Chappel CD; Gaffney DK
    Cancer; 2006 Nov; 107(9):2127-33. PubMed ID: 16998937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of the treatment and prognosis of recurrent breast phyllodes tumor].
    Fang Y; Gao JD; Tian YT; Xie YQ; Zhen S
    Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):72-4. PubMed ID: 19538877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant phyllodes tumor of the breast: treatment and prognosis.
    Mituś J; Reinfuss M; Mituś JW; Jakubowicz J; Blecharz P; Wysocki WM; Skotnicki P
    Breast J; 2014; 20(6):639-44. PubMed ID: 25227987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
    Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
    Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phyllodes tumor: an unexpected tumor of the breast. A report on six patients.
    Stranzl H; Peintinger F; Hackl A
    Strahlenther Onkol; 2004 Mar; 180(3):148-51. PubMed ID: 14991202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Recurrence of Malignant Phyllodes Tumors of the Breast.
    Park HJ; Ryu HS; Kim K; Shin KH; Han W; Noh DY
    In Vivo; 2019; 33(1):263-269. PubMed ID: 30587634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phyllodes tumors of the breast diagnostic and therapeutic dilemmas.
    Fajdić J; Gotovac N; Hrgović Z; Kristek J; Horvat V; Kaufmann M
    Onkologie; 2007 Mar; 30(3):113-8. PubMed ID: 17341897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant cystosarcoma phyllodes.
    Staren ED; Lynch G; Boyle C; Witt TR; Bines SD
    Am Surg; 1994 Aug; 60(8):583-5. PubMed ID: 8030812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of phyllodes breast tumors.
    Guillot E; Couturaud B; Reyal F; Curnier A; Ravinet J; Laé M; Bollet M; Pierga JY; Salmon R; Fitoussi A;
    Breast J; 2011; 17(2):129-37. PubMed ID: 21251125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant phyllodes tumor of the breast: local control rates with surgery alone.
    Pezner RD; Schultheiss TE; Paz IB
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):710-3. PubMed ID: 18234448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast.
    Jang JH; Choi MY; Lee SK; Kim S; Kim J; Lee J; Jung SP; Choe JH; Kim JH; Kim JS; Cho EY; Lee JE; Nam SJ; Yang JH
    Ann Surg Oncol; 2012 Aug; 19(8):2612-7. PubMed ID: 22476816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of postoperative time for adjuvant radiotherapy in malignant phyllodes tumor: An institutional experience.
    Yogi V; Singh OP; Malviya A; Ghori HU
    J Cancer Res Ther; 2018; 14(5):1054-1058. PubMed ID: 30197347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of malignant phyllodes tumors of the breast: the experience of the Institut Curie].
    Haberer S; Laé M; Seegers V; Pierga JY; Salmon R; Kirova YM; Dendale R; Campana F; Reyal F; Miranda O; Fourquet A; Bollet MA
    Cancer Radiother; 2009 Jul; 13(4):305-12. PubMed ID: 19524472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phyllodes tumors of the breast: The British Columbia Cancer Agency experience.
    Rodrigues MF; Truong PT; McKevitt EC; Weir LM; Knowling MA; Wai ES
    Cancer Radiother; 2018 Apr; 22(2):112-119. PubMed ID: 29523388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant radiotherapy for phyllodes tumor of breast.
    Chaney AW; Pollack A; McNeese MD; Zagars GK
    Radiat Oncol Investig; 1998; 6(6):264-7. PubMed ID: 9885942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant and borderline phyllodes tumors of the breast: a multicenter study of 362 patients (KROG 16-08).
    Choi N; Kim K; Shin KH; Kim Y; Moon HG; Park W; Choi DH; Kim SS; Ahn SD; Kim TH; Chun M; Kim YB; Kim S; Choi BO; Kim JH
    Breast Cancer Res Treat; 2018 Sep; 171(2):335-344. PubMed ID: 29808288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.